Nocturnal melatonin secretion and risk of type 2 diabetes : a prospective cohort study
(2026) In The Journal of clinical endocrinology and metabolism 111(6). p.1705-1712- Abstract
CONTEXT: Melatonin regulates circadian rhythms and influences glucose metabolism. Altered melatonin secretion may contribute to the pathogenesis of type 2 diabetes (T2D), but prospective population-based evidence is scarce.
OBJECTIVE: To examine whether low nocturnal melatonin secretion is associated with an increased risk of incident T2D in adults.
METHODS: This prospective cohort study, with follow-up from 2013 to 2023 (median 6.5 years), included a total of 4491 adults (52% women, aged 18-75 years) without T2D and melatonin supplementation at baseline, from the Malmö Offspring Study, a population-based cohort in southern Sweden. Incident T2D was identified via national and regional health registers. Nocturnal melatonin... (More)
CONTEXT: Melatonin regulates circadian rhythms and influences glucose metabolism. Altered melatonin secretion may contribute to the pathogenesis of type 2 diabetes (T2D), but prospective population-based evidence is scarce.
OBJECTIVE: To examine whether low nocturnal melatonin secretion is associated with an increased risk of incident T2D in adults.
METHODS: This prospective cohort study, with follow-up from 2013 to 2023 (median 6.5 years), included a total of 4491 adults (52% women, aged 18-75 years) without T2D and melatonin supplementation at baseline, from the Malmö Offspring Study, a population-based cohort in southern Sweden. Incident T2D was identified via national and regional health registers. Nocturnal melatonin secretion was assessed as the urinary 6-sulfatoxymelatonin-to-creatinine ratio (aMT6s/Cr) from first-morning urine samples, categorized into sex-specific quintiles.
RESULTS: During follow-up, 171 participants developed T2D. Participants in the lowest quintile of aMT6s/Cr had a higher T2D risk than those in quintiles 2 to 5 (multivariable adjusted hazard ratio [HR] 1.51, 95% CI 1.09-2.09). The association remained significant after additional adjustment for sleep duration and disruption (HR 1.54, 95% CI 1.11-2.13). When analyzing T2D development per 1-SD higher sex-standardized log aMT6s/Cr, the HR was 0.84 (95% CI 0.73-0.97). Associations were consistent across sex, age, and BMI subgroups.
CONCLUSION: Low nocturnal melatonin secretion was independently associated with a higher incidence of T2D in adults. A key limitation is the reliance on a single morning urine sample to estimate melatonin secretion. The findings support circadian regulation as a determinant of metabolic health and warrant further investigation of melatonin pathways in diabetes prevention.
(Less)
- author
- Sojakka Smith, Einar
LU
; Franzén, Anna
LU
; Pihlsgård, Mats
LU
; Nilsson, Peter M
LU
; Timpka, Simon
LU
and Enhörning, Sofia
LU
- organization
- publishing date
- 2026-05-19
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Humans, Diabetes Mellitus, Type 2/epidemiology, Melatonin/urine, Female, Middle Aged, Adult, Male, Prospective Studies, Aged, Circadian Rhythm/physiology, Adolescent, Sweden/epidemiology, Young Adult, Risk Factors, Follow-Up Studies, Incidence, Biomarkers/urine
- in
- The Journal of clinical endocrinology and metabolism
- volume
- 111
- issue
- 6
- pages
- 1705 - 1712
- publisher
- Oxford University Press
- external identifiers
-
- pmid:41389002
- scopus:105038841282
- ISSN
- 1945-7197
- DOI
- 10.1210/clinem/dgaf667
- language
- English
- LU publication?
- yes
- additional info
- © The Author(s) 2025. Published by Oxford University Press on behalf of the Endocrine Society.
- id
- 313ddaf6-f6b5-446e-a3c1-3cb19121555d
- date added to LUP
- 2026-05-29 14:57:10
- date last changed
- 2026-06-02 03:12:48
@article{313ddaf6-f6b5-446e-a3c1-3cb19121555d,
abstract = {{<p>CONTEXT: Melatonin regulates circadian rhythms and influences glucose metabolism. Altered melatonin secretion may contribute to the pathogenesis of type 2 diabetes (T2D), but prospective population-based evidence is scarce.</p><p>OBJECTIVE: To examine whether low nocturnal melatonin secretion is associated with an increased risk of incident T2D in adults.</p><p>METHODS: This prospective cohort study, with follow-up from 2013 to 2023 (median 6.5 years), included a total of 4491 adults (52% women, aged 18-75 years) without T2D and melatonin supplementation at baseline, from the Malmö Offspring Study, a population-based cohort in southern Sweden. Incident T2D was identified via national and regional health registers. Nocturnal melatonin secretion was assessed as the urinary 6-sulfatoxymelatonin-to-creatinine ratio (aMT6s/Cr) from first-morning urine samples, categorized into sex-specific quintiles.</p><p>RESULTS: During follow-up, 171 participants developed T2D. Participants in the lowest quintile of aMT6s/Cr had a higher T2D risk than those in quintiles 2 to 5 (multivariable adjusted hazard ratio [HR] 1.51, 95% CI 1.09-2.09). The association remained significant after additional adjustment for sleep duration and disruption (HR 1.54, 95% CI 1.11-2.13). When analyzing T2D development per 1-SD higher sex-standardized log aMT6s/Cr, the HR was 0.84 (95% CI 0.73-0.97). Associations were consistent across sex, age, and BMI subgroups.</p><p>CONCLUSION: Low nocturnal melatonin secretion was independently associated with a higher incidence of T2D in adults. A key limitation is the reliance on a single morning urine sample to estimate melatonin secretion. The findings support circadian regulation as a determinant of metabolic health and warrant further investigation of melatonin pathways in diabetes prevention.</p>}},
author = {{Sojakka Smith, Einar and Franzén, Anna and Pihlsgård, Mats and Nilsson, Peter M and Timpka, Simon and Enhörning, Sofia}},
issn = {{1945-7197}},
keywords = {{Humans; Diabetes Mellitus, Type 2/epidemiology; Melatonin/urine; Female; Middle Aged; Adult; Male; Prospective Studies; Aged; Circadian Rhythm/physiology; Adolescent; Sweden/epidemiology; Young Adult; Risk Factors; Follow-Up Studies; Incidence; Biomarkers/urine}},
language = {{eng}},
month = {{05}},
number = {{6}},
pages = {{1705--1712}},
publisher = {{Oxford University Press}},
series = {{The Journal of clinical endocrinology and metabolism}},
title = {{Nocturnal melatonin secretion and risk of type 2 diabetes : a prospective cohort study}},
url = {{http://dx.doi.org/10.1210/clinem/dgaf667}},
doi = {{10.1210/clinem/dgaf667}},
volume = {{111}},
year = {{2026}},
}